<?xml-stylesheet type='text/xsl' href='rsspretty.xsl' version='1.0'?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <atom:link href="http://www.law360.com/company_articles/533" rel="self" type="application/rss+xml"/>
    <title>Law360: Boston Scientific</title>
    <link>http://www.law360.com/</link>
    <description>Latest articles for organization: Boston Scientific</description>
    <copyright>Copyright 2009 Portfolio Media, Inc.</copyright>
    <language>en-US</language>
    <image>
      <url>http://www.law360.com/images/headings/logo.gif</url>
      <title>Law360</title>
      <link>http://www.law360.com/</link>
    </image>
    <item>
      <title>Boston Scientific To Pay $296M To Settle Probe</title>
      <link>http://www.law360.com/articles/132778</link>
      <description>Boston Scientific Corp. subsidiary Guidant Corp. will plead guilty to two misdemeanor charges and pay $296 million to end a U.S. Department of Justice probe into cardiac defibrillator product advisories it issued. 
</description>
      <guid>http://www.law360.com/articles/132778</guid>
    </item>
    <item>
      <title>Wyeth, Cordis Ask To Boot Boston Scientific Stent Case</title>
      <link>http://www.law360.com/articles/130360</link>
      <description>Wyeth Inc. and Cordis Corp. have asked a judge to dismiss or transfer a declaratory judgment suit filed by Boston Scientific Corp. in a fight over a patent related to drug coatings in stents, saying a suit they filed earlier elsewhere should take precedence.</description>
      <guid>http://www.law360.com/articles/130360</guid>
    </item>
    <item>
      <title>Guidant Investors Lose Bid To Revive Class Action</title>
      <link>http://www.law360.com/articles/129650</link>
      <description>Guidant Corp. has prevailed in a challenge by investors to the dismissal of a putative securities class action that alleged the medical device maker glossed over problems with its defibrillators and their impact on its aborted merger with Johnson &amp; Johnson, leading to billions of dollars in shareholder losses.</description>
      <guid>http://www.law360.com/articles/129650</guid>
    </item>
    <item>
      <title>Thermal Scalpel Sews Up Cutting Tool Patent Spat</title>
      <link>http://www.law360.com/articles/128279</link>
      <description>Thermal Scalpel LLC's patent infringement suit over an electrically heated surgical cutting tool is wrapping up, with a federal judge putting the case on hold as the patent company concludes settlement talks with the remaining defendants, Boston Scientific Corp. and St. Jude Medical Inc.</description>
      <guid>http://www.law360.com/articles/128279</guid>
    </item>
    <item>
      <title>Thermal Scalpel Cuts Tyco, Covidien From IP Suit</title>
      <link>http://www.law360.com/articles/126880</link>
      <description>Thermal Scalpel LLC has dropped Covidien Ltd. and Tyco Healthcare Group LP from a patent infringement lawsuit accusing roughly a dozen companies of infringing a patent for an electrically heated surgical cutting tool that can cauterize tissue as well as make incisions.
</description>
      <guid>http://www.law360.com/articles/126880</guid>
    </item>
    <item>
      <title>2 Juries To Hear Last Cordis, Boston Sci Stent Claims</title>
      <link>http://www.law360.com/articles/126076</link>
      <description>Cordis Corp.'s and Boston Scientific Corp.'s opposing willfulness and damages claims over three patents that remain at issue in the firms' decade-long infringement battle over stent technology will be heard in separate trials by different juries, a judge has ruled, following a landmark $716 million settlement resolving more than a dozen of the companies' lawsuits.</description>
      <guid>http://www.law360.com/articles/126076</guid>
    </item>
    <item>
      <title>Boston Scientific To Pay Cordis $716M In Stent War</title>
      <link>http://www.law360.com/articles/125307</link>
      <description>Following more than a decade of litigation, Boston Scientific Corp. has agreed to fork over a whopping $716 million to Johnson &amp; Johnson unit Cordis Corp. to settle more than a dozen lawsuits over stent technology.
</description>
      <guid>http://www.law360.com/articles/125307</guid>
    </item>
    <item>
      <title>Cordis Wins 2nd Dismissal Of Stent Patent Suit</title>
      <link>http://www.law360.com/articles/124459</link>
      <description>Having vacated a prior final judgment ruling due to a procedural error, a federal judge has again dismissed medical device maker MarcTec LLC's infringement suit against Johnson &amp; Johnson subsidiary Cordis Corp. over stents.
</description>
      <guid>http://www.law360.com/articles/124459</guid>
    </item>
    <item>
      <title>Wyeth, Cordis Sue Abbott, Boston Sci Over Stent</title>
      <link>http://www.law360.com/articles/123945</link>
      <description>Medical device manufacturers Wyeth and Cordis Corp. claim in a federal court suit filed Tuesday that stents made and sold by Boston Scientific Corp. and Abbott Laboratories infringe the companies' new patent relating to drug coatings in stents.</description>
      <guid>http://www.law360.com/articles/123945</guid>
    </item>
    <item>
      <title>Guidant Found Not Liable In Shocking Pacemaker Suit</title>
      <link>http://www.law360.com/articles/123611</link>
      <description>Boston Scientific Corp. unit Guidant Corp. has won a suit against a Pennsylvania pacemaker recipient who claimed that Guidant representatives present at the operation to install the device failed to correct an alleged error by the doctor.</description>
      <guid>http://www.law360.com/articles/123611</guid>
    </item>
    <item>
      <title>Conrad O'Brien Snags Ex-Synthes Patent Chief</title>
      <link>http://www.law360.com/articles/123255</link>
      <description>After more than a decade of in-house work, the former chief patent counsel for medical device maker Synthes Inc. has joined Philadelphia law firm Conrad O'Brien PC, where he will work to build the firm's intellectual property practice.</description>
      <guid>http://www.law360.com/articles/123255</guid>
    </item>
    <item>
      <title>Guidant Cleared In Death Of Toddler With Pacemaker</title>
      <link>http://www.law360.com/articles/121524</link>
      <description>Guidant Corp., a subsidiary of Boston Scientific Corp., has been found not liable by an Indiana county jury in a wrongful death suit brought by the family of a 14-month-old girl who died in 2005 after a Guidant pacemaker was implanted in her heart. </description>
      <guid>http://www.law360.com/articles/121524</guid>
    </item>
    <item>
      <title>Wyeth Loses Bid To Oust Howrey From Stent Suit</title>
      <link>http://www.law360.com/articles/118613</link>
      <description>Howrey LLP can represent Boston Scientific Corp. in several stent patent lawsuits against Wyeth and Johnson &amp; Johnson Inc., a federal judge has said, rejecting Wyeth's complaints of conflict of interest.</description>
      <guid>http://www.law360.com/articles/118613</guid>
    </item>
    <item>
      <title>Radiologist Targets Abbott Labs Over Stent Patent</title>
      <link>http://www.law360.com/articles/118252</link>
      <description>A New Jersey radiologist who won a major infringement verdict against Boston Scientific Corp. in 2008 over a type of drug-eluting coronary stent system has sued Abbott Laboratories over the same patent.</description>
      <guid>http://www.law360.com/articles/118252</guid>
    </item>
    <item>
      <title>Boston Scientific Stent Patent Spat Booted From Del.</title>
      <link>http://www.law360.com/articles/118348</link>
      <description>A federal judge has rejected Boston Scientific Corp.'s attempt to litigate a dispute over inventor W. Henry Wall's cardiovascular stent patent in Delaware, ruling that the court lacks personal jurisdiction over the Texas holding company for Wall's patent.</description>
      <guid>http://www.law360.com/articles/118348</guid>
    </item>
    <item>
      <title>Method Patents Not Covered By 271(f): Fed. Circ.</title>
      <link>http://www.law360.com/articles/117463</link>
      <description>In Cardiac Pacemakers Inc.&#8217;s long-running patent infringement fight against St. Jude Medical Inc. over implantable defibrillators, a federal appeals court has ruled en banc that a statute used by patent holders to assert patents to products originating in the U.S. and assembled in other countries does not apply to method patents.</description>
      <guid>http://www.law360.com/articles/117463</guid>
    </item>
    <item>
      <title>Cordis Stent Patents Found Enforceable On Remand</title>
      <link>http://www.law360.com/articles/115921</link>
      <description>A federal judge has ruled on remand that two of Cordis Corp.'s patents related to medical stents are in fact enforceable, reversing an earlier ruling in a long-running infringement dispute brought by Cordis against rival Boston Scientific Corp.</description>
      <guid>http://www.law360.com/articles/115921</guid>
    </item>
    <item>
      <title>Q&amp;A With Dickstein Shapiro's Gary Hoffman </title>
      <link>http://www.law360.com/articles/111797</link>
      <description>Seeking broad discovery may be great, but can we review 10 million documents if all electronically stored documents are produced? People need to learn how to focus the request and production while still complying with the rules, says Gary M. Hoffman, leader of Dickstein Shapiro LLP's intellectual property practice.</description>
      <guid>http://www.law360.com/articles/111797</guid>
    </item>
    <item>
      <title>Q&amp;A With Faegre &amp; Benson's Joseph Price</title>
      <link>http://www.law360.com/articles/109395</link>
      <description>A wave of litigation involving biologics and perhaps &#8220;personalized medicine&#8221; may be around the corner. The technology and rapid scientific advances in these areas are guaranteed to catch the attention of the plaintiffs bar, says Joseph M. Price, head of Faegre &amp; Benson LLP's drug and medical device litigation practice.</description>
      <guid>http://www.law360.com/articles/109395</guid>
    </item>
    <item>
      <title>Medtronic To Pay Abbott $400M To Quell Stent Suits</title>
      <link>http://www.law360.com/articles/113324</link>
      <description>Medtronic Inc. has agreed to pay Abbott Laboratories $400 million to settle all pending intellectual property litigation between the two companies worldwide over four patent families related to stents and rapid-exchange balloon catheters, the medical device makers said Monday.</description>
      <guid>http://www.law360.com/articles/113324</guid>
    </item>
  </channel>
</rss>
